EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Assessment of brain‐derived extracellular vesicle enrichment for blood biomarker analysis in age‐related neurodegenerative diseases: An international overview

AmanPreet Badhwar, Yael Hirschberg, Natalia Valle-Tamayo, M Florencia Iulita, Chinedu T Udeh-Momoh, Anna Matton, Rawan M Tarawneh, Robert A Rissman, Aurélie Ledreux, Charisse N Winston, Arsalan S Haqqani, Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment: Biofluid Based Biomarkers Professional Interest Area‐Exosome Worki…

Alzheimer's & Dementia · 2024-07 · 20 (7) · 4411-4422

DOI: 10.1002/alz.13823 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 12.06.2024. Verfasst von AmanPreet Badhwar und 11 weiteren Autor:innen. Beteiligte Einrichtung: Département de pharmacologie et physiologie, Institut de Génie Biomédical, Faculté de Médecine, Université de Montréal, Montréal, Quebec, Canada. Hauptthemen laut MEDLINE: Extracellular Vesicles, Neurodegenerative Diseases, Biomarkers, Brain. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, Flemish Institute for Technological Research, UNM Grand Challenges Initiative.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Brain‐derived extracellular vesicles (BEVs) in blood allows for minimally‐invasive investigations of central nervous system (CNS) ‐specific markers of age‐related neurodegenerative diseases (NDDs). Polymer‐based EV‐ and immunoprecipitation (IP)‐based BEV‐enrichment protocols from blood have gained popularity. We systematically investigated protocol consistency across studies, and determined CNS‐specificity of proteins associated with these protocols. METHODS NDD articles investigating BEVs in blood using polymer‐based and/or IP‐based BEV enrichment protocols were systematically identified, and protocols compared. Proteins used for BEV‐enrichment and/or post‐enrichment were assessed for CNS‐ and brain‐cell‐type‐specificity, extracellular domains (ECD+), and presence in EV‐databases. RESULTS A total of 82.1% of studies used polymer‐based (ExoQuick) EV‐enrichment, and 92.3% used L1CAM for IP‐based BEV‐enrichment. Centrifugation times differed across studies. A total of 26.8% of 82 proteins systematically identified were CNS‐specific: 50% ECD+, 77.3% were listed in EV‐databases. CONCLUSIONS We identified protocol steps requiring standardization, and recommend additional CNS‐specific proteins that can be used for BEV‐enrichment or as BEV‐biomarkers. Highlights Across NDDs, we identified protocols commonly used for EV/BEV enrichment from blood. We identified protocol steps showing variability that require harmonization. We assessed CNS‐specificity of proteins used for BEV‐enrichment or found in BEV cargo. CNS‐specific EV proteins with ECD+ or without were identified. We recommend evaluation of blood‐BEV enrichment using these additional ECD+ proteins.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesNeurodegenerative DiseasesBiomarkersBrainHumans

Stichwörter der Autor:innen

Alzheimer's diseaseage‐related neurodegenerative diseasesbiofluid based biomarkersbloodbrain‐derived extracellular vesiclesexosomesimmunoprecipitation‐based enrichmentmicrovesiclesnovel biomarkersprotocol variability

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Département de pharmacologie et physiologie, Institut de Génie Biomédical, Faculté de Médecine, Université de Montréal, Montréal, Quebec, Canada.
  • Multiomics Investigation of Neurodegenerative Diseases (MIND) lab, Centre de recherche de l'Institut Universitaire de Gériatrie, Montréal, Quebec, Canada.
  • Centre for Proteomics, University of Antwerp, Antwerp, Belgium.
  • Health Unit, Flemish Institute for Technological Research (VITO), Mol, Belgium.
  • Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Calle San Quintí, Barcelona, Spain.
  • Ageing Epidemiology research unit, School of Public Health, Imperial College London, London, UK.

Förderung

  • NIA NIH HHS
  • Flemish Institute for Technological Research
  • UNM Grand Challenges Initiative
  • NIH HHS
  • NINDS NIH HHS
  • Fondation Courtois
  • Fonds de Recherche Québec-Santé
  • National Institutes of Health

Zitieren

APA

Badhwar, A., Hirschberg, Y., Valle-Tamayo, N., Iulita, M. F., Udeh-Momoh, C. T., Matton, A., Tarawneh, R. M., Rissman, R. A., Ledreux, A., Winston, C. N., Haqqani, A. S., & Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment: Biofluid Based Biomarkers Professional Interest Area‐Exosome Worki… (2024). Assessment of brain‐derived extracellular vesicle enrichment for blood biomarker analysis in age‐related neurodegenerative diseases: An international overview. Alzheimer's & Dementia, 20(7), 4411-4422. https://doi.org/10.1002/alz.13823

Vancouver

Badhwar A, Hirschberg Y, Valle-Tamayo N, Iulita MF, Udeh-Momoh CT, Matton A, et al. Assessment of brain‐derived extracellular vesicle enrichment for blood biomarker analysis in age‐related neurodegenerative diseases: An international overview. Alzheimer's & Dementia. 2024;20(7):4411-4422. doi:10.1002/alz.13823

BibTeX
@article{Badhwar2024,
  author = {Badhwar, AmanPreet and Hirschberg, Yael and Valle-Tamayo, Natalia and Iulita, M Florencia and Udeh-Momoh, Chinedu T and Matton, Anna and Tarawneh, Rawan M and Rissman, Robert A and Ledreux, Aurélie and Winston, Charisse N and Haqqani, Arsalan S and Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment: Biofluid Based Biomarkers Professional Interest Area‐Exosome Worki…, Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment: Biofluid Based Biomarkers Professional Interest Area‐Exosome Worki…},
  title = {Assessment of brain‐derived extracellular vesicle enrichment for blood biomarker analysis in age‐related neurodegenerative diseases: An international overview},
  journal = {Alzheimer's & Dementia},
  year = {2024},
  volume = {20},
  number = {7},
  pages = {4411--4422},
  doi = {10.1002/alz.13823}
}
Kostenlos starten →